BERTOLOTTI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 18.967
EU - Europa 8.457
AS - Asia 3.378
SA - Sud America 79
AF - Africa 22
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 11
Totale 30.929
Nazione #
US - Stati Uniti d'America 18.818
GB - Regno Unito 2.517
IT - Italia 2.279
SG - Singapore 1.083
CN - Cina 1.000
SE - Svezia 915
DE - Germania 807
UA - Ucraina 545
HK - Hong Kong 541
TR - Turchia 421
FI - Finlandia 329
RU - Federazione Russa 264
FR - Francia 251
BG - Bulgaria 220
CA - Canada 142
ID - Indonesia 87
IN - India 72
NL - Olanda 72
BR - Brasile 52
IE - Irlanda 51
BE - Belgio 43
ES - Italia 31
MY - Malesia 27
CH - Svizzera 22
CZ - Repubblica Ceca 22
IR - Iran 20
JP - Giappone 19
VN - Vietnam 17
LT - Lituania 16
TW - Taiwan 16
GR - Grecia 14
BD - Bangladesh 13
PH - Filippine 13
AU - Australia 12
AR - Argentina 10
ET - Etiopia 10
KR - Corea 10
RO - Romania 10
EU - Europa 8
SI - Slovenia 8
CL - Cile 7
IQ - Iraq 7
MX - Messico 7
MK - Macedonia 6
PK - Pakistan 6
AT - Austria 5
NO - Norvegia 5
PL - Polonia 5
TH - Thailandia 5
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
SA - Arabia Saudita 4
UG - Uganda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
MC - Monaco 2
MD - Moldavia 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AZ - Azerbaigian 1
CY - Cipro 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 30.929
Città #
Fairfield 2.377
Santa Clara 2.262
Southend 2.013
Woodbridge 1.495
Chandler 1.322
Houston 1.283
Ashburn 1.222
Jacksonville 1.033
Seattle 867
Dearborn 829
Ann Arbor 820
Singapore 790
Cambridge 785
Wilmington 783
Nyköping 571
Hong Kong 534
Modena 354
San Diego 295
Beijing 293
Izmir 277
Princeton 241
Sofia 215
Eugene 187
Helsinki 172
Milan 142
New York 137
Moscow 104
Des Moines 102
Shanghai 87
London 86
Jakarta 83
Fremont 82
Rome 82
Bologna 80
Redwood City 75
Toronto 71
Boardman 57
Bremen 57
Grafing 57
Falls Church 54
Dublin 44
Brussels 41
North York 39
Munich 37
San Mateo 37
Frankfurt am Main 35
Mountain View 35
Norwalk 33
Parma 33
Guangzhou 30
Padova 30
Kunming 29
Los Angeles 29
Hefei 28
Nanjing 28
Florence 26
Turin 24
Brno 20
Catania 20
Dongguan 20
Kilburn 20
Ottawa 19
Jinan 18
Phoenix 18
Verona 17
Hounslow 16
Indiana 16
Naples 15
Paris 15
Bari 14
Dong Ket 14
Nanchang 14
Reggio Emilia 14
Rimini 14
Washington 14
Wuhan 14
Chiswick 13
Auburn Hills 12
Chicago 12
Amsterdam 11
Palermo 11
Leawood 10
Monmouth Junction 10
San Francisco 10
São Paulo 10
Taipei 10
Albignasego 9
Livorno 9
San Jose 9
Santeramo in Colle 9
Shenyang 9
Taglio Di Po 9
Chengdu 8
Formia 8
Fuzhou 8
Kocaeli 8
Perugia 8
Prescot 8
Ravenna 8
Rio Saliceto 8
Totale 23.473
Nome #
MoCA 7.1: Multicenter Validation of the First Italian Version of Montreal Cognitive Assessment 611
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 305
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 291
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 280
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 261
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 258
Physical exercise for late life depression: effects on cognition and disability 257
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 243
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 238
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 236
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 234
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 234
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 233
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 231
La clinica metabolica per il trattamento della lipodistrofia 229
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 229
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 227
Risk of birth defects associated with maternal pregestational diabetes. 224
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 223
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 218
Telomere length elongation after weight loss intervention in obese adults 217
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 215
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 214
The relationship between age and fat infiltration in liver and muscle 213
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 213
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 213
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 211
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 211
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention 210
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 208
Nonalcoholic fatty liver disease and aging: epidemiology to management 208
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 208
Analgesic drug taking: Beliefs and behavior among headache patients 207
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 207
Liver X receptors and copper metabolism: New frontiers for the oxysterol receptors 205
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 200
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report 200
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 200
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 198
Effects of cholecalciferol supplementation in patients with stable heart failure and low vitamin D levels (ECSPLOIT-D). A double-blind, randomized, placebo-controlled pilot study 197
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 196
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 195
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 194
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 193
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 193
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 193
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 191
Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation. 190
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 188
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 187
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 187
The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo 186
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 184
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 181
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study 180
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 177
Endocrine and liver interaction: the role of endocrine pathways in NASH 175
Case of an old man with aortic dissection type A and enlarging meningioma 174
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 173
Review article: effect of bile salt pool composition on hepatic and biliary functions 172
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 171
Advances in the comprehension of the pathophysiology of bile secretion 170
Hypertensive disease in the elderly: Predictors of clinical evolution in a follow-up study 170
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 170
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 169
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 169
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy 169
Effects of acute changes of bile acid pool composition on biliary lipid secretion 168
Disposition of naproxen after oral administration during and between migraine attacks. 167
Inhibition of intestinal cholesterol absorption by surfomer [alpha-olefin maleic acid] affects hepatic cholesterol synthesis and low density lipoprotein transport in hamsters fed a fat-enriched diet 165
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 164
Statins and HCV: a complex issue 163
Review article: hyperlipidaemia and cardiovascular risk 162
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 162
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 161
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 161
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 160
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 158
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 157
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 157
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 156
Reply 154
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 153
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 153
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 153
Nonalcoholic fatty liver disease induced by leuprorelin acetate 153
Anatomia e fisiologia delle vie biliari 151
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 150
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 150
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 149
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 148
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 148
Lancellotti G, Bergamini L, Finelli ME, Guerzoni V, Mannina M, Zanasi A, Facchini MC, Squarzina PB, Bertolotti M, Mussi C. Fattori associati al delirium post-chirurgico in pazienti fratturati di femore: l’esperienza in ortogeriatria. 147
In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment 146
Effect of ursocholic acid on bile lipid secretion and composition 146
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 146
Bile acid structure and regulation of biliary protein secretion and composition in man 145
Influence of age and sex on serum concentrations of total dimeric activin A 145
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 144
Risk communication at the time of Coronavirus: are we washing our hand of COVID-19? 144
Totale 19.400
Categoria #
all - tutte 133.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.564 0 0 0 0 0 862 962 529 494 209 311 197
2020/20214.843 436 174 415 628 591 285 464 574 234 506 342 194
2021/20224.377 183 479 311 389 101 218 314 266 552 243 808 513
2022/20233.991 417 361 312 350 448 576 102 430 510 74 218 193
2023/20242.853 128 163 184 271 527 231 366 339 103 111 135 295
2024/20254.384 320 152 215 638 1.816 1.243 0 0 0 0 0 0
Totale 31.245